U.S. approves first marijuana plant-derived drug for epilepsy

(Reuters) - The U.S. health regulator approved GW Pharmaceuticals Plc's epilepsy treatment on Monday, making it the first cannabis-based drug to win approval in the country and opening floodgates for more research into the medicinal properties of cannabis.

Pride and worry, Britain's free health service turns 70

MILTON KEYNES, England (Reuters) - Free, good quality healthcare for everyone, from cradle to grave. That was the mission of Britain’s National Health Service when it was founded on July 5, 1948.

China says United States domestic opioid market the crux of crisis

BEIJING (Reuters) - China's drug control agency on Monday said the United States should do more to cut its demand for opioids to tackle the use of synthetic drug fentanyl, but it vowed to step up cooperation after Chinese production of the substance had been blamed for fuelling the U.S. opioid crisis.

Pfizer's breast cancer drug combo falls short of survival goal

(Reuters) - Pfizer Inc said on Monday a combination of its breast cancer drug, Ibrance, and another drug was not statistically significant in extending overall survival in certain patients, the secondary goal of a late-stage trial.

Clamor for GSK shingles shot points to bigger profits

LONDON (Reuters) - GlaxoSmithKline is facing "unprecedented" demand for its new shingles vaccine Shingrix, suggesting the product could be a bigger money-spinner than the company and analysts initially thought.

Study preserves hopes for Roche's Tecentriq in lung cancer

ZURICH (Reuters) - Swiss drugmaker Roche's hopes of having the first immunotherapy cocktail to be approved as an initial treatment for an aggressive form of lung cancer remained intact on Monday after a trial showed positive survival data.

Australian watchdog appeals to high court on Pfizer's alleged abuse of market power

MELBOURNE (Reuters) - Australia's competition watchdog said on Monday it would appeal to the nation's high court for a ruling on whether Pfizer Inc used its market power to limit competition for its cholesterol-lowering drug Lipitor.

Dementia venture fund raises $350 million to hunt new drugs

LONDON (Reuters) - A venture capital fund dedicated to finding new ways to prevent and treat dementia has raised $350 million, far exceeding the initial target of $200 million set on its launch in 2015.

Flight attendants may have higher cancer rates

(Reuters Health) - U.S. flight attendants may be more likely than other Americans to develop several types of cancer including tumors of the breast, uterus, cervix, thyroid and skin, new research suggests.

Most doctors would give HIV prevention drugs to teens

(Reuters Health) - Last month U.S. regulators said a pill that helps prevent infection with HIV is safe for use by adolescents, and a study suggests most physicians would be willing to prescribe this medicine to teens.

Related Videos

Treadmill tests show polar bears to be efficient walkers

Polar bears consume no more energy than similarly sized animals while walking, according to new research which counters previous scientific thinking. The findings are important because Arctic ice shrinkage is forcing the creatures to travel further distances to hunt seals. Jim Drury reports.

Norway tests tiny electric plane, sees passenger flights by 2025

Norway has tested a two-seater electric plane, predicting a start to passenger flights by 2025 if new aviation technologies match a green shift that has made Norwegians the world's top buyers of electric cars, as Reuters' Alister Doyle discovered. Jim Drury reports.
You might like...

Check out our Reuters News Now daily briefing for hand-picked stories from Reuters editors. It's all the news you need to start your day.

Subscribe here